Medical Journals

The Role of Glycine in Hepatic Ischemia-reperfusion Injury.

Authors:
  • Habib M M
  • Hodgson H J F
  • Davidson B R

From: University Department of Surgery, Royal Free & University College Medical School, Royal Free Hampstead NHS Trust Hospital, London NW3 2QGUK.

Current pharmaceutical design

  • Publish Date: 2006
  • ISSN: 1381-6128
  • Volume: 12
  • Issue: 23
  • Pages: 2953-67
  • Medium: Print
  • Language: English
  • Citation (JAMA): Habib M M, Hodgson H J F, Davidson B R, et al. The Role of Glycine in Hepatic Ischemia-reperfusion Injury.. Curr. Pharm. Des. 2006;12:2953-67

Abstract

Glycine is a non-essential amino acid which is cheap, easily available and relatively non-toxic. It is composed of a single carbon attached to an amino and a carboxyl group, with a molecular weight of 75. It is involved in the production of bile, nucleic acids, porphyrins and creatine phosphate. It is part of the normal human diet and is used clinically, as an irrigant solution in urological and gynaecological procedures. Glycine has broad spectrum anti-inflammatory, cytoprotective and immunomodulatory properties whose therapeutic role has largely been un-investigated. Since the demonstration of its cytoprotective effect on hypoxic cultured renal tubule cells, further research has established its mechanism of anti-inflammatory action, which depends on stimulation of glycine sensitive chloride channel receptors on the cell membrane. The mechanism of non-specific cytoprotective effect which is present even in chloride and calcium free media is not clear. However glycine is currently being used experimentally, in human liver transplant recipients and has been shown to be beneficial in animal models of ischemia-reperfusion injury (IRI) in liver and several other organs. This review addresses the properties of glycine, its mechanism of action and its role in modulating IRI with special reference to the liver, with the aim of stimulating translational research into the potential role of glycine as a pharmaceutical agent.

Mesh Headings (Keywords): Animals, Glycine, Humans, Liver, Liver Diseases, Reperfusion Injury


Check for Full Text / PubMed Unique Identifier (PMID): 16918424


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.